US Stock MarketDetailed Quotes
PXMD PaxMedica
- 0.704
- +0.012+1.76%
Close Apr 25 16:00 ET
5.26MMarket Cap-64P/E (TTM)
0.705High0.678Low214.68KVolume0.705Open0.692Pre Close148.91KTurnover3.15%Turnover RatioLossP/E (Static)7.47MShares29.75052wk High1.55P/B4.80MFloat Cap0.37252wk Low--Dividend TTM6.81MShs Float178.160Historical High--Div YieldTTM3.92%Amplitude0.372Historical Low0.693Avg Price1Lot Size
About PaxMedica Company
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Company Profile
SymbolPXMD
Company NamePaxMedica
Listing DateAug 26, 2022
Issue Price5.25
Founded2018
CEOMr. Howard J. Weisman
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address303 South Broadway,Suite 125
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591
Phone1-914-987-2876
Websitehttp://www.paxmedica.com
Company Executives
- Name
- Position
- Salary
- Howard J. Weisman
- Chief Executive Officer and Chairman of the Board
- 1.05M
- Stephen D. Sheldon
- Chief Financial Officer, Principal Accounting Officer and Chief Operating Officer
- 635.87K
- Dr. David W. Hough, M.D.
- Chief Medical Officer
- 266.78K
- Zachary Rome
- Director
- 322.23K
- Karen LaRochelle
- Independent Director
- 83.31K
- Charles J. Casamento
- Lead Independent Director
- 98.83K
- Dr. John F. Coelho
- Independent Director
- 79.47K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg